Furthermore, increased chemosensitivity induced by the downregulation of miR-1238 in the temozolomide-resistant GBM cells was reversed by CAV1 downregulation, suggesting miR-1238 controls CAV1 expression, leading to the drug resistance [85]. Here, CAV1 is linked to glioblastoma.